<DOC>
	<DOCNO>NCT02605785</DOCNO>
	<brief_summary>This study design learn overall tau burden brain patient Progressive Supranuclear Palsy ( PSP ) .</brief_summary>
	<brief_title>A Molecular Anatomic Imaging Analysis Tau Progressive Supranuclear Palsy</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<criteria>Must 40 year age . Must informant study partner provide independent information functioning . Must meet criterion possible probable Progressive Supranuclear Palsy . To fulfill criterion possible PSP , subject must gradually progressive disorder either vertical ( upward downward ) supranuclear palsy slow vertical saccade prominent postural instability fall first year disease onset . To fulfill criterion probable PSP , subject must vertical ( upward downward gaze ) supranuclear palsy prominent postural instability fall first year disease onset . Must symptom &lt; 4 year . Must able ambulate independently . Must PSP rating scale score le 40 Montreal Cognitive Assessment score great 20 . Subjects exclude meet criterion another neurodegenerative disease ( include corticobasal syndrome , frontotemporal dementia , primary progressive aphasia , Alzheimer 's disease , multiple system atrophy Parkinson 's disease ) symptoms necessary fulfill inclusion criterion possible PSP . Subjects concurrent illness could account symptom , traumatic brain injury , encephalitis , stroke developmental syndromes exclude . Women pregnant postpartum breastfeeding exclude . Subjects exclude study unable undergo tauPET scan due prolong QT interval ECG , follow genetic condition increase chance cancer : Cowden disease , Lynch syndrome , hypogammaglobulinemia , WiskottAldrich syndrome , Down 's syndrome . Subjects also exclude MRI contraindicate ( metal head , cardiac pace maker , e.t.c . ) , severe claustrophobia , condition may confound brain imaging study ( e.g . structural abnormality , include subdural hematoma , intracranial neoplasm large cortical infarct ) , medically unstable medication might affect brain structure metabolism ( e.g . chemotherapy ) . Subjects also exclude informant , consent research .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PSP</keyword>
</DOC>